Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Cytokeratin 19 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Cytokeratin 19 in WB, IF, FACS und IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN6937691

Kurzübersicht für Rekombinanter Cytokeratin 19 Antikörper (ABIN6937691)

Target

Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 333
  • 120
  • 87
  • 8
  • 7
  • 6
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 176
  • 172
  • 3
  • 2
  • 1
Maus

Klonalität

  • 204
  • 150
Monoklonal

Konjugat

  • 164
  • 38
  • 20
  • 12
  • 10
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
Dieser Cytokeratin 19 Antikörper ist unkonjugiert

Applikation

  • 260
  • 153
  • 109
  • 84
  • 79
  • 60
  • 47
  • 45
  • 41
  • 39
  • 36
  • 32
  • 22
  • 7
  • 6
  • 6
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Klon

RKRT19-799
  • Spezifität

    This MAb reacts with the rod domain of human cytokeratin-19 (CK19), a polypeptide of 40 kDa. Its epitope maps between amino acid 312-335. CK19 is expressed in sweat gland, mammary gland ductal and secretory cells, bile ducts, gastrointestinal tract, bladder urothelium, oral epithelia, esophagus, and ectocervical epithelium. Anti-CK19 reacts with a wide variety of epithelial malignancies including adenocarcinomas of the colon, stomach, pancreas, biliary tract, liver, and breast. Perhaps the most useful application is the identification of thyroid carcinoma of the papillary type, although 50 % -60 % of follicular carcinomas are also labeled. Anti-CK19 is a useful marker for detection of tumor cells in lymph nodes, peripheral blood, bone marrow and breast cancer.

    Keine Kreuzreaktivität

    Frettchen, Ratte (Rattus)

    Kreuzreaktivität (Details)

    Human. Does not react with Rat or Ferret.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human full-length KRT19 protein

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: MCF-7, HeLa oe Hep-G2 cells. Human breast cancer tissue.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Cytokeratin 19 (KRT19) (Keratin 19 (KRT19))

    Andere Bezeichnung

    KRT19

    Hintergrund

    K19, k1cs, Keratin 19 Keratin Type i 40kD, krt19,Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker)
    Cellular localisation: Cytoplasmic

    Molekulargewicht

    40kDa

    Gen-ID

    3880, 654568

    UniProt

    P08727
Sie sind hier:
Chat with us!